Bayer Logo Bayer Logo Bayer Logo

CKD and T2D: Patient management

Optimising the patient journey

Management of patients with chronic kidney disease and type 2 diabetes

Chronic kidney disease is defined as the presence of abnormalities in kidney structure or function for >3 months with implications for the patient’s health.1,2 The clinical diagnosis of chronic kidney disease in a patient with diabetes is based on the presence of albuminuria (urine albumin-to-creatinine ratio ≥30 mg/g) and/or reduced kidney function (estimated glomerular filtration rate <60 ml/min/1.73 m2), in the absence of signs or symptoms of other primary causes of kidney damage.2-4

 

 

Alt tag

Clinical diagnosis of chronic kidney disease in type 2 diabetes2 

 

*Elevated UACR should be confirmed in the absence of urinary tract infection with two additional early morning urine samples collected over the next 2 months

CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; UACR, urinary albumin-to-creatinine ratio

1. Kidney Disease Improving Global Outcomes. Kidney Int Suppl 2013;3:1–163

2. Levey AS, et al. JAMA 2015;313:837–846

3. National Kidney Foundation. Am J Kidney Dis 2007;49(Suppl 2):S1–S180

4. American Diabetes Association. Diabetes Care 2020;43(Suppl 1):S135–S151

 

MA-M_FIN-ALL-0200-1